Unjha Formulations Quarterly Results for Trading Insights
UNJHAFOR • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹0 Cr
QMarch 2025
Unjha Formulations Quarterly Results Key Highlights
- Revenue of ₹14 Cr in March 2025 (+0.0% vs March 2025, -26.3% vs March 2024)
- EBITDA of ₹1 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 4.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹0.91 in March 2025 (+0.0% vs March 2025)
Unjha Formulations Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 14 | 14 | 19 | 13 | 14 | - | - |
| Net Profit (₹ Cr) | 1 | 0 | 0 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 1 | 1 | 1 | 1 | 1 | - | - |
| EPS (₹) | 2.30 | 0.91 | 0.62 | 0.63 | 0.56 | - | - |
| Operating Margin (%) | 6.0% | 4.0% | 3.0% | 3.0% | 2.0% | - | - |
Unjha Formulations Share Price Trend Around Quarterly Results
Visualize Unjha Formulations's 1-year price movement across quarterly results — ideal for logging trades in Unjha Formulations share price
chart using Tickjournal. All values in ₹.
Related Pages for Unjha Formulations
Additional stock information and data for UNJHAFOR
Revenue Trend (₹ Cr)
March 2023
13
March 2024
19
March 2025
14
2026
14
Net Profit Trend (₹ Cr)
March 2023
0
March 2024
0
March 2025
0
2026
1
Operating Margin Trend (%)
March 2023
3.0%
March 2024
3.0%
March 2025
4.0%
2026
6.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Unjha Formulations quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1825.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 140.5 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6352.5 | 2,860 | 689 | +7.1% | - | 24.1% | 244.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4431.2 | 3,219 | 591 | +11.3% | - | 18.4% | 252.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1325.5 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.9 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1329.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores